Connect with us

Hi, what are you looking for?

Health

Zenflow Gains FDA Clearance for Innovative Single-Use Cystoscope

Zenflow, Inc., a medical device company based in South San Francisco, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking product, the Zenflow Spring ® Scope and Camera Control Unit (CCU). This marks the introduction of the first single-use cystoscope designed to enhance urological procedures, featuring a working channel that is more than 80% larger than existing single-use models.

The Zenflow Spring Scope enables urologists to conduct flexible cystoscopy, which is the most frequently performed office-based procedure in this specialty. This technique is crucial for diagnosing and treating various conditions affecting the lower urinary tract. In the United States, there are approximately 1.2 million cystoscopies conducted annually, highlighting the importance of this procedure in patient care.

Enhanced Features and Patient Comfort

Dr. Bilal Chughtai, Chief of Urology at Plainview Hospital and a lead investigator for the Zenflow Spring System, emphasized the benefits of this technology, stating, “This new cystoscope technology delivers clear imaging while also allowing us to provide advanced diagnostics and therapeutics in the comfort of our office. It’s an exciting and much-anticipated innovation in the field.”

Zenflow’s CEO, Shreya Mehta, expressed her enthusiasm regarding the FDA clearance, stating, “With advanced imaging, catheter flexibility, and a large working channel, the Spring Scope is a meaningful innovation in its own right, and a key enabler and differentiator for our forthcoming BPH therapy, the Zenflow Spring Implant and Delivery System.”

This product is part of Zenflow’s commitment to improving urological care through innovative design and patient-centric solutions. The Spring System, which includes the Spring Scope, is designed specifically to optimize the experience for men suffering from benign prostatic hyperplasia (BPH) symptoms. It is important to note that the Zenflow Spring Implant and Delivery System remains an investigational device and is not yet approved for commercial sale.

Market Implications and Future Outlook

The introduction of the Zenflow Spring Scope is expected to significantly impact the market for cystoscopes, which is projected to grow in the coming years. Research indicates that advancements in technology, such as 3D visualization and digital capabilities, are driving demand for more effective diagnostic tools in urology. As the healthcare landscape evolves, Zenflow aims to position itself as a leader in this sector.

For further information about Zenflow and its products, interested parties can visit their official website at www.zenflow.com and follow the company on LinkedIn for the latest updates.

As the medical community anticipates the broader availability of the Spring Scope, the emphasis on patient comfort and improved procedural efficacy is likely to resonate well with both healthcare providers and patients alike.

“This new cystoscope technology delivers clear imaging while also allowing us to provide advanced diagnostics and therapeutics in the comfort of our office.” – Dr. Bilal Chughtai

With this FDA clearance, Zenflow is poised to make significant strides in urological care, setting the stage for further innovations that prioritize patient outcomes.

You May Also Like

Sports

The UFC event in Abu Dhabi on July 26, 2025, featured a record-breaking performance from Steven Nguyen, who achieved an unprecedented feat by knocking...

Lifestyle

Shares of **Amerant Bancorp** (NYSE:AMTB) received an upgrade from Wall Street Zen on March 10, 2024, transitioning from a hold rating to a buy...

Entertainment

The upcoming Netflix series, Bon Appétit, Your Majesty, is making headlines due to a significant casting change just ten days before filming commenced. Originally...

Entertainment

**Kat Izzo Defends Relationship with Dale Moss Amid Controversy** Kat Izzo, a contestant from the reality series *Bachelor in Paradise*, publicly affirmed her relationship...

Top Stories

UPDATE: Sydney Sweeney’s Baskin-Robbins advertisement is making waves online as backlash intensifies over her recent American Eagle campaign. Just days after critics condemned the...

Politics

King Charles has reportedly outlined specific conditions that Prince Harry must meet to facilitate a potential reunion with the royal family. Following a discreet...

Top Stories

BREAKING: The historic Durango-La Plata Aquatic Center, a cornerstone of community recreation since its opening in August 1958, is facing imminent demolition as part...

Entertainment

Erin Bates Paine, known for her role on the reality show Bringing Up Bates, was admitted to the Intensive Care Unit (ICU) following complications...

Top Stories

URGENT UPDATE: Affordable motorcycle helmets under ₹1000 are now available for safety-conscious riders across India. With road safety becoming a pressing issue, these helmets...

Business

An off-Strip casino in Las Vegas has unveiled Nevada’s latest sportsbook, Boomer’s Sports Book, as part of a substantial renovation. The new facility opened...

Sports

The Las Vegas Aces secured a convincing victory over the Los Angeles Sparks, defeating them 89-74 on March 12, 2024, at Crypto.com Arena. This...

Sports

As the 2025 NFL season approaches, fantasy football enthusiasts are gearing up for their drafts, particularly focusing on tight ends. With players like Brock...

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.